Literatur
Ronkainen J, Aro P, Storskrubb T et al (2009) Natural history of non-erosive reflux disease, the kalixanda study, A population-based study. Gut 58 (Suppl II): OP132
Hoffman A, Sar F, Goetz M et al (2009) High definition plus colonoscopy combined with I-scan is superior in the detection and characterization of colorectal neoplasias compared to standard video colonoscopy? A prospective randomized trial. Gut 58 (Suppl II): OP371
Pohl H, Robertson DJ, Farkas DK et al (2009) Erosive and nonerosive reflux disease and risk for Esophageal Adenocarcinoma. Gut 58 (Suppl II): OP139
Kim M, Jung H, Choi K et al (2009) Natural history and management of gastric subpithelial tumors. Gut 58 (Suppl II): P0094
Nowakowska-Dulawa E, Nowak A, Marek T et al (2009) Urgent endoscopic sphincterotomy is beneficial for patients with Acute Biliary Pancreatitis (ABP) without Common Bile Duct Stones (CBDS)? A prospective randomized study. Gut 58 (Suppl II): OP116
Sacher-Huvelin S, Le Rhun M, Planche L et al (2009) Wireless capsule colonoscopy versus colonoscopy in patients at average or increased risk for colorectal cancer. Gut 58 (Suppl II): OP005
Van Gossum A, Munoz-Navas M, Fernandez-Urien I et al (2009) Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med 361: 264–270
Mas-De-Xaxars T, Aldeguer X et al (2009) Searching for representative bacteria in the colonic mucosa of colorectal cancer patients. Gut 58 (Suppl II): OP108
Wu S, Rhee KJ, Albesiano E et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016–1022
Zeuzem S, Sulkowski M, Lawitz E, McHutchison J et al (2009) Efficacy and safety of albinterferon alfa-2b in combination with ribavirin in treatment-naïve patients with chronic hepatitis C genotype 1. Oral presentation. 44th Annual Meeting of the European Association for the Study of the Liver
McHutchison J et al (2009) PROVE3 Final results and 1-year durability of SVR with telaprevir-based regimen in hepatitis C genotype 1-infected patients with prior non-response, viral breakthrough or relapse to peginterferon-alfa-2a/b and ribavirin therapy. Hepatology 50: 334A–335A
Reinisch W, Rubin DT, Bensimon AG et al (2009) Predictors of clinical response and relapse in Crohn’s disease. Gut 58 (Suppl II): OP151
Björkesten C af, Nieminen U, Turunen U et al (2009) TNF-alpha antagonists in Crohn’s disease: Results of endoscopy guided therapy. Gut 58 (Suppl II): P1800
Colombel J, Rutgeerts P, Reinisch W et al (2009) One year data from the sonic study: A randomized, double-blind trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn’s disease naive to immunomodulators and biologic therapy. Gut 58 (Suppl II): OP323
Maas M, Van Dam RM et al (2009) Wait-and-see policy in clinical complete responders to chemoradiation in rectal cancer: A promising alternative. Gut 58 (Suppl II): P1682
Interessenkonflikt
Keine Angaben.
Author information
Authors and Affiliations
Corresponding author
Additional information
UEGW-Update-Veranstaltungen
Die United European Gastroenterology Week (UEGW) hat sich als zentraler Kongress der Gastroenterologie für den europäischen Raum etabliert. Die Fülle an neuen und wegweisenden Daten hat im Vergleich zu den Vorjahren deutlich zugenommen. Vor diesem Hintergrund wird die neue deutsche Kongressserie UEGW-Update aufrechterhalten, damit die wesentlichen Erkenntnisse im gemeinsamen Dialog herausgestellt werden können (www.uegw-update.de). Im Rahmen der UEGW-Update-Veranstaltung werden alle Präsentationen der UEGW topographisch geordnet und analysiert. Die wesentlichen Erkenntnisse werden während sechs verschiedener Veranstaltungen in Deutschland praxisnah von verschiedenen anerkannten Experten zusammengefasst.
Rights and permissions
About this article
Cite this article
Kiesslich, R., Labenz, J. UEGW-Update. Gastroenterologe 5, 156–158 (2010). https://doi.org/10.1007/s11377-009-0398-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-009-0398-8